Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
about
Blood Biomarkers for Evaluation of Perinatal EncephalopathyUpdate on Inflammatory Biomarkers and Treatments in Ischemic StrokeSerological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.Syrosingopine sensitizes cancer cells to killing by metforminNeuron specific enolase: a promising therapeutic target in acute spinal cord injury.Reversible Brain Abnormalities in People Without Signs of Mountain Sickness During High-Altitude Exposure.Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor CellsIs neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resectionMerkel cells and Meissner's corpuscles in human digital skin display Piezo2 immunoreactivity.Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia.Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.Serum neuron-specific enolase levels at presentation and long-term neurological sequelae after acute charcoal burning-induced carbon monoxide poisoning.Uncovering the proteome response of murine neuroblastoma cells against low-dose exposure to saxitoxin.Prognostic value of neuron-specific enolase (NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review.Association between serum neuron-specific enolase, age, overweight, and structural MRI patterns in 901 subjects.Serum neuron specific enolase may be a marker to predict the severity and outcome of cerebral venous thrombosis.Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.Diagnostic value of tumour markers in pleural effusions.Crystal structure of enolase from Drosophila melanogaster.Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype.A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor.Favorable prognostic role of tropomodulins in neuroblastoma.High-Intensity Interval Training Is Associated With Alterations in Blood Biomarkers Related to Brain InjuryThe association of serum neuron-specific enolase with other disease markers in chronic obstructive pulmonary disease: A case-control studyIdentifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?Clinical and laboratory factors related to acute isolated vertigo or dizziness and cerebral infarctionCirculating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization
P2860
Q26741134-19365074-3944-424A-AC74-E9BC6A843B5BQ28078744-371C0C9A-2A56-45B8-882E-FEC933C8DD8FQ33829604-0D5B3874-AE4D-417C-925A-BD801177D03EQ34548130-5ECE2675-E8B2-465D-80FD-7883D46A1025Q36892833-4FEE1FA4-E74D-456E-A05B-B2B4AFE93317Q37260640-0399F978-44D7-4F64-87CC-B69A77C0E523Q37611641-1615850B-3A8E-4E17-A73D-7C897147E60FQ38601874-8DBE6C56-281E-4395-BCC7-974E66AC42B6Q38763212-FF9892DB-CDB2-4AC1-A7B5-B783F1C0DA6BQ38947077-27BB10EB-57F1-49DB-8A8F-CD46ADEB847FQ38996164-3964319C-4952-4F78-9FCA-D06B594D327DQ42115077-EBE3CBA8-BB26-4424-A161-A963BA1A0418Q42515042-E747F7E4-8332-4FA1-BED0-44C596B01773Q47142222-81D43351-293D-4B5F-8FBD-8E3C3BFF5B1AQ47159086-2535F056-096E-4870-9A9A-02884A91CB9CQ47295063-799A21F8-0E20-4049-827B-8452BA2C39A5Q47306200-F91900A9-61A5-4F35-AB32-2EED4296A36CQ47441846-389E3084-FE70-470B-BB2A-32537DE1F52EQ47927312-A3410119-B13A-4542-B89E-F5ED5710742DQ47973617-78C3DBA4-550A-4D08-9AFC-049BF05B0B6DQ48518649-066DFDAF-EEE7-4DD5-AEF6-FA24F37C942FQ49804316-531A7963-1E30-412E-ABB1-71040AB7F1B3Q49822225-A7DD52BF-FB78-402F-8B23-846585C0F586Q50199472-4DD0D081-362F-49CD-A446-0D0D980ED2C5Q50935633-662DA149-966C-4BE6-AC19-B65BCE4D5AFCQ55265819-DCB30C7C-1961-4784-8993-3C5C0EC5951DQ55285562-E1D7D4DD-54FA-4E77-9A9A-B02937F1EBB9Q55397125-2ACC478E-F74A-4998-9438-787917BDD5BDQ57490229-E08A5B73-2E09-4131-9EF3-1B191497F9D0Q57822996-874511A7-1514-42EE-9E17-2E044E39554FQ58591218-A77E1DD3-80E6-4160-860B-C72BE53BCC6EQ58788115-4626BDD5-5E91-4637-BA86-7C17D62FB53FQ58788799-21CA0B48-3BF6-445E-8209-8EF751A0D29B
P2860
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@ast
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@en
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@nl
type
label
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@ast
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@en
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@nl
prefLabel
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@ast
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@en
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
@nl
P1476
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects
@en
P2093
Maria Antonietta Isgrò
Roberto Scatena
P304
P356
10.1007/978-94-017-7215-0_9
P407
P577
2015-01-01T00:00:00Z